{
  "id": 197,
  "language": "english",
  "hallucination": "no",
  "ground_truth_source": "text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Co-hosts",
      "inferred_vibe": "Informative and concerned"
    },
    "dialogue_turns": [
      {
        "speaker": "Host_A",
        "text": "Hey B, so I was reading this really interesting article about something pretty scary: antimicrobial resistance, or AMR.",
        "tts_text": "Hey B, so I was reading this really interesting article about something pretty scary: antimicrobial resistance, or A M R.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "Oh, yeah, AMR. That's, like, a huge deal, right? I've heard it called an 'invisible pandemic'.",
        "tts_text": "Oh, yeah, A M R. That's, like, a huge deal, right? I've heard it called an invisible pandemic.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Antimicrobial resistance is an invisible pandemic, said Dr Maringela Simão, Assistant-Director General for Access to Medicines.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Exactly! And the WHO, uh, they've actually developed this new tool called AWaRe to, you know, try and tackle it.",
        "tts_text": "Exactly! And the W H O, uh, they've actually developed this new tool called A W a R e to, you know, try and tackle it.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The AWaRe tool was developed by the WHO Essential Medicines List to contain rising resistance and make antibiotic use safer and more effective.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "AWaRe? What's that stand for, or what does it actually *do*?",
        "tts_text": "A W a R e? What's that stand for, or what does it actually do?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_A",
        "text": "It classifies antibiotics into three groups: Access, Watch, and Reserve. It's all about making antibiotic use safer, and, um, more effective.",
        "tts_text": "It classifies antibiotics into three groups: Access, Watch, and Reserve. It's all about making antibiotic use safer, and, um, more effective.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The AWaRe tool was developed by the WHO Essential Medicines List to contain rising resistance and make antibiotic use safer and more effective. It classifies antibiotics into three groups Access, Watch and Reserve...",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "So, like, guiding doctors on *which* antibiotic to use? Or when?",
        "tts_text": "So, like, guiding doctors on which antibiotic to use? Or when?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_A",
        "text": "Precisely! The big push is to get at least 60% of global consumption into the 'Access' group. These are narrow-spectrum antibiotics, so they're less likely to cause resistance, and um, often cheaper too.",
        "tts_text": "Precisely! The big push is to get at least sixty percent of global consumption into the Access group. These are narrow-spectrum antibiotics, so they're less likely to cause resistance, and um, often cheaper too.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The new campaign aims to increase the proportion of global consumption of antibiotics in the Access group to at least 60%... Using Access antibiotics lowers the risk of resistance because they are narrow-spectrum antibiotics (that target a specific microorganism rather than several). They are also less costly because they are available in generic formulations.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "Right, so 'Access' is the good stuff, less risky. And the 'Watch' and 'Reserve' groups are the ones we really need to, like, hang onto, [interrupts] for serious stuff?",
        "tts_text": "Right, so Access is the good stuff, less risky. And the Watch and Reserve groups are the ones we really need to, like, hang onto, for serious stuff?",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "...and those that must be used sparingly or preserved and used only as a last resort.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Yeah, exactly. Those are for when things are really tough, or as a last resort. Because, you know, over 50% of antibiotics in many countries are used inappropriately.",
        "tts_text": "Yeah, exactly. Those are for when things are really tough, or as a last resort. Because, you know, over fifty percent of antibiotics in many countries are used inappropriately.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Currently, it is estimated that more than 50% of antibiotics in many countries are used inappropriately such as for treatment of viruses when they only treat bacterial infections or use of the wrong (broader spectrum) antibiotic, thus contributing to the spread of antimicrobial resistance.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "Wow, over 50%? That's insane. Like, for viruses, when they only work for bacteria, or just the wrong type of antibiotic altogether, right?",
        "tts_text": "Wow, over fifty percent? That's insane. Like, for viruses, when they only work for bacteria, or just the wrong type of antibiotic altogether, right?",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Currently, it is estimated that more than 50% of antibiotics in many countries are used inappropriately such as for treatment of viruses when they only treat bacterial infections or use of the wrong (broader spectrum) antibiotic...",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Exactly, and that's just accelerating this resistance problem. Dr. Tedros from WHO said it threatens to undo a century of medical progress.",
        "tts_text": "Exactly, and that's just accelerating this resistance problem. Doctor Tedros from W H O said it threatens to undo a century of medical progress.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Antimicrobial resistance is one of the most urgent health risks of our time and threatens to undo a century of medical progress, said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "And it's not just about the effectiveness, is it? I mean, when antibiotics stop working, it means more expensive treatments, longer hospital stays. And, um, a huge burden on healthcare budgets.",
        "tts_text": "And it's not just about the effectiveness, is it? I mean, when antibiotics stop working, it means more expensive treatments, longer hospital stays. And, um, a huge burden on healthcare budgets.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "When antibiotics stop working effectively, more expensive treatments and hospital admissions are needed, taking a heavy toll on already stretched health budgets.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Totally. And ironically, in low-income countries, there are still huge gaps in *access* to even basic, effective antibiotics, leading to, like, childhood deaths from pneumonia.",
        "tts_text": "Totally. And ironically, in low-income countries, there are still huge gaps in access to even basic, effective antibiotics, leading to, like, childhood deaths from pneumonia.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "At the same time, many low- and middle-income countries experience vast gaps in access to effective and appropriate antibiotics. Childhood deaths due to pneumonia (estimated globally at close to one million per year) because of lack of access to antibiotics remain frequent in many parts of the world.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "So, it's this crazy balance, right? Ensuring people get life-saving drugs, but also making sure we don't overuse them and make them useless.",
        "tts_text": "So, it's this crazy balance, right? Ensuring people get life-saving drugs, but also making sure we don't overuse them and make them useless.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "All countries must strike a balance between ensuring access to life-saving antibiotics and slowing drug resistance by reserving the use of some antibiotics for the hardest-to-treat infections.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Yeah, it's a tightrope. And that's where AWaRe really comes in – to guide policymakers and doctors. Because without new antibiotics, improving how we use the ones we have is, um, crucial.",
        "tts_text": "Yeah, it's a tightrope. And that's where A W a R e really comes in - to guide policymakers and doctors. Because without new antibiotics, improving how we use the ones we have is, um, crucial.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "By classifying antibiotics into three distinct groups, and advising on when to use them, AWaRe makes it easier for policy-makers, prescribers and health workers to select the right antibiotic at the right time... In the absence of new significant investments into the development of new antibiotics, improving the use of antibiotics is one of the key actions needed to curb further emergence and spread of antimicrobial resistance.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "It really is like an invisible pandemic. We're already seeing signs of, like, a 'post-antibiotic era' where some infections are becoming untreatable.",
        "tts_text": "It really is like an invisible pandemic. We're already seeing signs of, like, a post-antibiotic era where some infections are becoming untreatable.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "We are already starting to see signs of a post-antibiotic era, with the emergence of infections that are untreatable by all classes of antibiotics.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Exactly. We just have to protect these precious last-line antibiotics to ensure we can still treat serious infections. It's, uh, literally a matter of life and death.",
        "tts_text": "Exactly. We just have to protect these precious last-line antibiotics to ensure we can still treat serious infections. It's, uh, literally a matter of life and death.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "We must safeguard these precious last-line antibiotics to ensure we can still treat and prevent serious infections.",
        "confidence": 1.0,
        "priority": "high"
      }
    ]
  }
}